Applications of Molecular Testing in Clinical Laboratories for the Diagnosis and Control of Gonorrhea

• Tapsall JW : Antibiotic resistance in Neisseria gonorrheae is diminishing available treatment options for gonorrhea – some possible remedies.Expert Rev. Anti-Infect. Ther. (2006) (In Press).
   PubMedGoogle Scholar
• Kihlstrom E , DanielssonD: Advances in biology, management and prevention of infections caused by Chlamydia trachomatis and Neisseria gonorrheae.Curr. Opin. Infect. Dis.7 , 25–33 (1994).
   Web of Science ®Google Scholar
• Australian Gonococcal Surveillance Programme: changing patterns of gonococcal infection in Australia, 1981–1987. Med. J. Aust.149 , 609–612 (1988).
   PubMed Web of Science ®Google Scholar
• O‘Reilly KR , PiotP: International perspectives on individual and community approaches to the prevention of sexually transmitted disease and human immunodeficiency virus infection.J. Infect. Dis.174 , S214–S222 (1996).
   PubMed Web of Science ®Google Scholar
• Miller PJ , TorzilloPJ, HateleyW: Impact of improved diagnosis and treatment on prevalence of gonorrhea and chlamydial infection in remote Aboriginal communities on Anangu Pitjantjatjara Lands.Med. J. Aust.170 , 429–432 (1999).
   PubMed Web of Science ®Google Scholar
• Choudery B , RisleyCL, GhaniAC et al.: Identification of individuals with gonorrhea within sexual networks: a population-based study. Lancet368 , 139–146 (2006).
   PubMed Web of Science ®Google Scholar
• Kolader M -E, Dukers NHTM, van der Bij AK et al.: Molecular epidemiology of Neisseria gonorrheae in Amsterdam, The Netherlands, shows distinct heterosexual and homosexual networks. J. Clin. Microbiol.44 , 2689–2697 (2006).
   PubMed Web of Science ®Google Scholar
• WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme: Surveillance of antibiotic susceptibility of Neisseria gonorrheae in the WHO Western Pacific Region 1992–1994. Genitourin. Med.73 , 355–361 (1997).
   PubMedGoogle Scholar
• Sarafian SK , KnappJS: Molecular epidemiology of gonorrhea.Clin. Microbiol.2(Suppl. 2) , S49–S55 (1989).
   Web of Science ®Google Scholar
• Lum G , FreemanK, NguyenNL et al.: A cluster of culture positive gonococcal infections but with false-negative cppB-gene-based PCR. Sex. Transm. Infect.81 , 400–402 (2005).
   PubMed Web of Science ®Google Scholar
• Whiley DM , LeCornecGM, MackayIM, SiebertDJ, SlootsTP: A new confirmatory Neisseria gonorrheae real-time PCR assay targeting the porA pseudogene.Eur. J. Clin. Microbiol. Infect. Dis.23 , 705–710 (2004).
   PubMed Web of Science ®Google Scholar
• Limnios EA , Nguyen N-L, Ray S, McIver CJ, Tapsall JW: Dynamics of appearance and expansion of a prolyliminopeptidase-negative subtype among Neisseria gonorrheae isolates collected in Sydney, Australia, from 2002 to 2005. J. Clin. Microbiol.44 , 1400–1404 (2006).
   PubMed Web of Science ®Google Scholar
• Whiley DM , TapsallJW, SlootsT: Nucleic acid amplification testing for Neisseria gonorrhea: an ongoing challenge.J. Mol. Diag.8 , 3–15 (2006).
   PubMed Web of Science ®Google Scholar
• Smith DW , TapsallJW, LumG: Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrheae in Australia: a position paper on behalf of the Public Health Laboratory Network.Commun. Dis. Intell.29 , 358–365 (2005).
   Google Scholar
• Johnson RE , NewhallWJ, PappJR et al.: Screening tests to detect Chlamydia trachomatis and Neisseria gonorrheae infections. Morb. Mortal. Wkly Rep.51 , 1–48 (2002).
   Google Scholar
• Bruisten SM , NoordhoekGT, van den Brule AJC et al.: Multicenter validation of the cppB gene as a PCR target for detection of Neisseria gonorrheae. J. Clin. Microbiol.42 , 4332–4334 (2004).
   PubMed Web of Science ®Google Scholar
• Tapsall JW , LimniosEA, NguyenNL et al.: Problematic cppB-gene based assays may contribute to failure to confirm BD ProbeTEC PCR for Neisseria gonorrheae with a cppB-gene based PCR. J. Clin. Microbiol.43 , 2036–2037 (2005).
   PubMed Web of Science ®Google Scholar
• van Dyck E , IevenM, PattynS, van Damme L, Laga M: Detection of Chlamydia trachomatis and Neisseria gonorrheae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J. Clin. Microbiol.39 , 1751–1756 (2001).
   PubMed Web of Science ®Google Scholar
• Palmer HM , MallinsonH, WoodRL, HerringAJ: Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrheae.J. Clin. Microbiol.41 , 835–837 (2003).
   PubMed Web of Science ®Google Scholar
• National Pathology Accreditation Advisory Council: Laboratory accreditation standards and guidelines for nucleic acid detection and analysis. Australian Government Department of Health and Ageing, Canberra, Australia (2006).
   Google Scholar
• Kent CK , ChewJK, WongW et al.: Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in two clinical settings among men who have sex with men: San Francisco, California, 2003. Clin. Infect. Dis.42 , 67–74 (2005).
   Google Scholar
• Hanage WP , FraserC, SprattBG: Fuzzy species among recombinogenic bacteria.BMC Biol.3 , 6–13 (2006).
   Web of Science ®Google Scholar
• Peeling R , MabeyDCW, HolmesKK: Molecular techniques for HIV and STDs: implications for research and disease control in the new millennium. In:Sexually Transmitted Diseases Methods and Protocols. Peeling RW, Sparling PF (Eds). Humana Press, NJ, USA 219–231 (1999).
   Google Scholar
• Gerbase AC , RowleyJT, HeymannDH, BerkleySF, PiotP: Global prevalence and incidence estimates of selected curable STDs.Sex. Transm. Infect.74(Suppl. 1) , S12–S16 (1998).
   PubMed Web of Science ®Google Scholar
• Vickerman P , WattsC, AlaryM, MabeyD, PeelingRW: Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrheae in women.Sex. Transm. Inf.79 , 363–367 (2003).
   PubMed Web of Science ®Google Scholar
• Viscidi RP , DemmaJC: Genetic diversity of Neisseria gonorrheae housekeeping genes.J. Clin. Microbiol.41 , 197–204 (2003).
   PubMed Web of Science ®Google Scholar
• Bash MC , ZhuP, GulatiS, McKnewD, RicePA, LynnF: por variable-region typing by DNA probe hybridization is broadly applicable to epidemiological studies of Neisseria gonorrheae.J. Clin. Microbiol.43 , 1522–1530 (2005).
   PubMed Web of Science ®Google Scholar
• Martin IM , IsonCA, AanensenDM, FentonKA, SprattBG: Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area.J. Infect. Dis.189 , 1497–1505 (2004).
   PubMed Web of Science ®Google Scholar
• Tapsall JW : Monitoring antimicrobial resistance for public health action.Commun. Dis. Intell.27 , S70–S74 (2003).
   Google Scholar
• Giles J , HardickJ, YuengerJ, DanM, Reich K, Zenilman J: Use of applied biosystems 7900HT sequence detection system and Taqman assay for detection of quinolone-resistant Neisseria gonorrheae.J. Clin. Microbiol.42 , 3281–3283 (2004).
   PubMed Web of Science ®Google Scholar
• Giles JA , FalconioJ, YuengerJD, ZenilmanJM, DanM, BashMC: Quinolone resistance-determining region mutations and por type of Neisseria gonorrheae isolates: resistance surveillance and typing by molecular methodologies.J. Infect. Dis.189 , 2085–2093 (2004).
   PubMed Web of Science ®Google Scholar
• Ropp PA , HuM, OleskyM, NicholasRA: Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrheae.Antimicrob. Agents Chemother.46 , 769–777 (2002).
   PubMed Web of Science ®Google Scholar
• Lindback E , IslamS, UnemoM, LangC, WretlindB: Transformation of ciprofloxacin-resistant Neisseria gonorrheae gyrA, parE and porB1b genes.Int. J. Antimicrob. Agents (2006) (In Press).
   PubMed Web of Science ®Google Scholar
• Muratani T , AkasakaS, KobayashiT et al.: Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrheae in Japan. Antimicrob. Agents Chemother.45 , 3603–3606 (2001).
   PubMed Web of Science ®Google Scholar
• Ameyama S , OnoderaS, TakahataM et al.: Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrheae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother.46 , 3744–3749 (2002).
   PubMed Web of Science ®Google Scholar
• Ito M , DeguchiT, Mizutani K-S et al.: Emergence and spread of Neisseria gonorrheae clinical isolates harbouring mosaic-like structure of pencillin-binding 2 protein in central Japan. J. Clin. Microbiol.49 , 137–143 (2005).
   Google Scholar

Websites

• Tapsall JW: Antimicrobial resistance in Neisseria gonorrheae. WHO/CDS/CSR/DRS/2001.3. WHO, Geneva, Switzerland (2001). www.who.int/entity/drugresistance/ Antimicrobial_resistance_in_Neisseria_ gonorrheae.pdf
   Google Scholar
• Surveillance standards for antimicrobial resistance. WHO/CDS/CSR/DRS/2001.5 WHO, Geneva, Switzerland (2001). www.who.int/drugresistance/publications/WHO_CDS_CSR_DRS_2001_5/en/index.html
   Google Scholar
• Australian Gonococcal Surveillance Programme reports. www.health.gov.au/internet/wcms/Publishing.nsf/Content/cda-pubs-annlrpt-gonoanrep.htm
   Google Scholar
• CDC. Sexually transmitted disease surveillance 2003 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report (2003). Atlanta, Georgia, USA Department of Health and Human Services (2004). www.cdc.gov//GISP2003/
   Google Scholar
• WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme reports. www.who.int/entity/drugresistance/ Antimicrobial_resistance_in_Neisseria_ gonorrheae.pdf
   Google Scholar